If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,170.00    30.00 (0.58%)
Bid:
5,160.00
Ask:
5,165.00
Spread: 5.00 (0.097%)
Market Cap: £18.84b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

4 Jan 2022 09:54

RNS Number : 3425X
Coca-Cola HBC AG
04 January 2022
 

FOR IMMEDIATE RELEASE

04 January 2022

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that the deferred bonus award over shares of CHF 6.70 in the Company (the "Deferred Shares") granted under the Company's Management Incentive Plan to Zoran Bogdanovic, Chief Executive Officer, relating to a performance related annual bonus for 2018 vested on 31 December 2021. Following vesting, the PDMR sold sufficient Deferred Shares to cover his tax and other liabilities and the balance of the Deferred Shares was retained.

 PDMR

Number of shares granted under the Deferred Shares vesting

Number of shares sold to cover taxes and other liabilities

Number of shares retained

Zoran Bogdanovic, Chief Executive Officer

7,717

450

7,267

 

The Notification of Dealing Form can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

ZORAN BOGDANOVIC

 

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF EXECUTIVE OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

VESTING OF DEFERRED SHARES GRANTED IN MARCH 2019 UNDER THE COMPANY'S MANAGEMENT INCENTIVE PLAN

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

7,717

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

7,717

196,551.99 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE DEFERRED SHARES

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

25.47 GBP

450

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

25.47 GBP

450

11,461.50 GBP

e)

 

Date of the transaction

 

2021-12-31

f)

 

Place of the transaction

 

XLON

 

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKQBPCBKKBDK
Date   Source Headline
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights
25th Jan 202212:50 pmRNSCompletes acquisition of further stake in CCBCE
18th Jan 20222:20 pmRNSDirector/PDMR Shareholding
13th Jan 20228:53 amRNSCompletes acquisition of a majority stake in CCBCE
7th Jan 20222:14 pmRNSAthens Exchange trading date of ordinary shares
4th Jan 202210:55 amRNSIssue of equity and total voting rights
4th Jan 20229:54 amRNSDirector/PDMR Shareholding
31st Dec 202110:27 amRNSDirector/PDMR Shareholding
31st Dec 202110:19 amRNSDirector/PDMR Shareholding
20th Dec 20213:58 pmRNSDirector/PDMR Shareholding
20th Dec 20213:43 pmRNSDirector/PDMR Shareholding
17th Dec 20213:38 pmRNSPost 2021 AGM Shareholder Engagement
13th Dec 20213:29 pmRNSDirector/PDMR Shareholding
7th Dec 202110:29 amRNSDirector/PDMR Shareholding
1st Dec 20218:34 amRNSIssue of equity and total voting rights
18th Nov 20211:12 pmRNSDirector/PDMR Shareholding
15th Nov 20213:16 pmRNSDirector/PDMR Shareholding
15th Nov 20212:03 pmRNSDirector/PDMR Shareholding
12th Nov 20219:17 amRNSDirector/PDMR Shareholding
12th Nov 20218:45 amRNSDirector/PDMR Shareholding
11th Nov 202111:57 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.